Use of Obesity Medications in the Era of GLP-1 Agonists: An Expert Panel Discussion
Jamy Ard, Lydia Alexander, Daniel Bessesen, Karlijn Burridge, Sean Hasan Hashmi · 2024
Read Use of Obesity Medications in the Era of GLP-1 Agonists: An Expert Panel Discussion by Jamy Ard, Lydia Alexander, Daniel Bessesen, Karlijn Burridge, Sean Hasan Hashmi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11648321.txt.
Description
Jamy Ard and co-authors present an expert panel discussion from two thousand twenty-four on obesity medicines in the age of GLP-1 drugs. These long-acting drugs mimic a gut hormone and have shown strong effects on weight and metabolic health. With obesity affecting more than two in five adults in the United States, access and long-term care are pressing issues.
The panel, gathered by a medical journal, brings together specialists in obesity medicine. They discuss clinical use of the new drug class, now called third-generation anti-obesity medication. They also weigh effects on health systems and society, and the need for fair, lasting access. The discussion format lets each expert speak from practice, with Ard opening as moderator and society president.
Catalog record
| CREATOR | Jamy Ard, Lydia Alexander, Daniel Bessesen, Karlijn Burridge, Sean Hasan Hashmi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |